About us
Cephalon Inc., founded in 1987, in Philadelphia, USA, by Frank Baldino Jr., Ph.D., a researcher in neurosciences, is an international biopharmaceutical company dedicated to the discovery, development and marketing of innovative branded specialty as well as generic products in 100 countries.
At Cephalon, 4 000 people worldwide are committed to improving patients’ lives.


